Johnson & Johnson is in touch with the central government to start clinical trial of its much awaited single-dose COVID-19 vaccine in India, the company said on Friday, according to news agency Reuters. “We are in discussions with the (government) with the objective of starting a bridging clinical study of our Janssen COVID-19 vaccine candidate in India, subject to local regulatory approvals,” a local J&J representative said, Reuters reported.
The COVID-19 vaccine developed US healthcare giant, has already been approved in United States, the European Union and other nations including Thailand and South Africa.
